{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:55:44Z","timestamp":1793404544597,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/wnf.0b013e318296e630","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T11:59:00Z","timestamp":1371556740000},"page":"122-127","source":"Crossref","is-referenced-by-count":7,"title":["Dysport (Botulinum Toxin Type A) in Routine Therapeutic Usage"],"prefix":"10.1097","volume":"36","author":[{"given":"Jean","family":"Hubble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Coleman","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"7","key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","article-title":"Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.","volume":"20","author":"Truong","year":"2005","journal-title":"Mov Disord"},{"issue":"5","key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.parkreldis.2010.03.002","article-title":"Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.","volume":"16","author":"Truong","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s004150170028","article-title":"Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study.","volume":"248","author":"Wissel","year":"2001","journal-title":"J Neurol"},{"issue":"1","key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.64.1.13","article-title":"What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group.","volume":"64","author":"Poewe","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.","volume":"31","author":"Bakheit","year":"2000","journal-title":"Stroke"},{"issue":"4","key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000069495","article-title":"A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.","volume":"15","author":"Pittock","year":"2003","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000008121","article-title":"Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.","volume":"43","author":"Rollnik","year":"2000","journal-title":"Eur Neurol"},{"issue":"7","key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880180708","article-title":"Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.","volume":"18","author":"Van den Bergh","year":"1995","journal-title":"Muscle Nerve"},{"issue":"5","key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2007.11.003","article-title":"Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial.","volume":"14","author":"Truong","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/0269215508097861","article-title":"Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.","volume":"23","author":"Hu","year":"2009","journal-title":"Clin Rehabil"},{"issue":"1","key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apmr.2008.04.030","article-title":"Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.","volume":"90","author":"Gracies","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/09638280400009360","article-title":"The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.","volume":"27","author":"Suputtitada","year":"2005","journal-title":"Disabil Rehabil"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e318296e630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:15:26Z","timestamp":1620976526000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201307000-00005"}},"subtitle":["A Telephone Needs Assessment Survey of European Physicians to Evaluate Current Awareness and Adherence to Product Labeling Changes"],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e318296e630","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}